Characterization of an Ovarian Cancer Activating Factor in Ascites From Ovarian Cancer Patients

Clinical Cancer Research

Volumn 1, Issue 10, 1995, Pages 1223-1232

  Xu, Yan ^a   Boynton, John D ^b   Frankel, Andrea ^b   Fang, Xian Jun ^b   Sharma, Ajay ^b   Hurteau, Jean ^b   Mills, Gordon B ^b   Goodbody, Anne ^c   Casey, Graham ^d   Gaudett, Douglas C ^e   Holub, Bruce J ^e   Mellors, Alan ^e  

^a UNIVERSITY OF TEXAS   (United States)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c NPS Pharmaceutical Inc   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LYSOPHOSPHATIDIC ACID; OVARY CANCER ACTIVATING FACTOR; PHOSPHATIDIC ACID; POLYUNSATURATED FATTY ACID; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; ASCITES FLUID; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ASCITES; CALCIUM; CELL DIVISION; FATTY ACIDS; FEMALE; GROWTH SUBSTANCES; HUMAN; LYSOPHOSPHOLIPIDS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; SPECTRUM ANALYSIS, MASS; SUPPORT, NON-U.S. GOV'T;

EID: 0028871499     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. American Cancer Society, Cancer facts & figures—1993. New York: American Cancer Society, Inc., 1993.
2. Petterson, F. (ed.). Annual Report on the Results of Treatment in Gynecological Cancer, Vol. 20. Stockholm: International Federation of Gynecology and Obstetrics, 1993.
3. Broxterman, H. J., Sprenkels-Schotte, C., Englen, P., Leyva, A., and Pinedo, H. Analysis of human ascites effect on clonogenic growth of human tumor cell lines and NRK-49F cells in soft agar. Int. J. Cell Cloning, 5: 158–169, 1987.
4. Mills, G. B., May, C., McGill, M., Roifman, C. M., and Mellors, A. A. A putative new growth factor in ascitic fluid from ovarian cancer patients: Identification, characterization, and mechanism of action. Cancer Res., 48: 1066–1071, 1988.
5. Mills, G. B., May, C, Hill, M., Campbell, S., Shaw, P., and Marks, A. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. J. Clin. Invest., 86: 85–855, 1990.
6. Wilson, A. P., Fox, H., Scott, I. V., Lee, H., Dent, M., and Golding, P. A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours. Br. J. Cancer, 63: 102–108, 1991.
7. Van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W. H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathway mediated by G proteins. Cell, 59: 45–54, 1989.
8. Van Corven, E. J., Van Rijswijk, A., Jalink, K., van Der Bend, R. L., van Blitterswijk, W. J., and Moolenaar, W. H. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Biochem. J., 281: 163–169, 1992.
9. Johnson, R. A., and Toews, M. L. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells. Mol. Pharmacol., 37: 296–303, 1990.
10. Kreps, D. M., Whittle, S. M., Hoffman, J. M., and Toews, M. L. Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation. FASEB J., 7: 1376–1380, 1993.
11. Proll, M. A., Clark, R. B., and Butcher, R. W. Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein Ni. Mol. Pharmacol., 28: 331–337, 1985.
12. Imamura, F., Horai, T., Mukai, M., Shinkai, K., Sawada, M., and Akedo, H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun., 193: 497–503, 1993.
13. Tigyi, G., Dyer, D. L., and Miledi, R. Lysophosphatidic acid possesses dual action in cell proliferation. Proc. Natl. Acad. Sci. USA, 91: 1908–1912, 1994.
14. Watson, S. P., McConnell, R. T., and Lapetina, E. G. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action: Evidence against a second messenger role of lysophosphatidic acid. Biochem. J., 232: 61–66, 1985.
15. Gerrard, J. M., and Robinson, P. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta, 1001: 282–285, 1989.
16. Eichholitz, T., Jalink, K., Fahrenfort, I., and Moolenaar, W. H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J., 291: 677–680, 1993.
17. Moolenaar, W. H. LPA: a novel lipid mediator with diverse biological actions. Trends Cell Biol., 4: 213–218, 1994.
18. Buick, R. N., Pullano, R., and Trent, J. M. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res., 45: 3668–3676, 1985.
19. Bacus, S., Stancovski, I., Huberman, E., Chin, D., Hurwitz, E., Mills, G. B., Ullrich, A., Sela, M., and Yarden, Y. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. Cancer Res., 52: 2580–2589, 1992.
20. Mills, G. B., Hashimoto, S., Hurteau, J., Schmandt, R., Campbell, S., May, C., Hill, P., Shaw, P., Buckman, R., and Hogg, D. Regulation of growth of human ovarian cancer cells. In: F. Sharp, P. Mason, and W. Creaseman (eds.), Ovarian Cancer 2: Biology Diagnosis and Management, pp. 127–143. London: chapman and Hall Medical, 1992.
21. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
22. Bligh, E. G., and Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37: 911-917, 1959.
23. Schacht, J. Extraction and purification of polyphosphoinositides. Methods Enzymol., 72: 626–631, 1981.
24. 14C]stearoyl-labelled lysophospholipids in collagen-stimulated human platelets. Biochim. Biophys. Acta, 1081: 92–98, 1991.
25. Gaudette, D. C., Aukema, H. A., Jolly, C. A., Chapkin, R. S., and Holub, B. J. Mass and fatty acid composition of the 3-phosphorylated phosphatidylinositol bisphosphate isomers in stimulated human platelets. J. Biol. Chem., 268: 13773–13776, 1993.
26. Skeaff, C. G., and Holub, B. J. Effect of dietary fish oil containing eicosapentaenoic acid on the fatty acid composition of platelet phospholipid and on the thrombin-stimulated phospholipid alterations in human platelets. In: M. Lagarde (ed.), Biology of Eicosanoids and Related Substances in Blood and Vascular Cells, Vol. 152, pp. 63–76. Paris: INSERM, 1987.
27. Juaneda, P., and Rocquelin, G. Rapid and convenient separation of phopsholipids and non phosphorus lipids from rat heart using silica cartridges. Lipids, 20: 40–41, 1985.
28. Merril, C. R. Gel-staining techniques. Methods Enzymol., 182: 477–488, 1990.
29. Brenner, M., Niederwieser, A., and Pataki, G. Amino acids and derivatives. In: E. Stahl (ed.). Thin-layer Chromatography, Ed. 2, pp. 747–748. Berlin: Springer-Verlag, 1969.
30. Das, A. K., and Hajra, A. K. Quantification, characterization and fatty acid composition of lysophosphatidic acid in diffrent rat tissues. Lipids, 24: 329–333, 1989.
31. Hoffman, L. M., and Jendrisak, J. Heat-labile phosphatase simplifies the preparation of dephosphorylated vector DNA. Gene, 88: 97–99, 1990.
32. Keesey, J. Biochemica Information, Ed. 1. Mannheim, Germany: Boehringer Mannheim, 1987.
33. Little, C. Phospholipase C from Bacillus cereus. Methods Enzymol., 71: 725-730, 1981.
34. Dennis, E. A., Rhee, S. G., Billah, M. M., and Hannun, Y. A. Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J., 5: 2068–2073, 1991.
35. Imamura, S., and Horiuti, Y. Purification of Streptomyces chromo- fuscus phospholipase D by hydrophobic affinity chromatography on palmitoyl cellulose. J. Biochem., 85: 79–85, 1979.
36. Okawa, Y., and Yamaguchi, T. J. Studies on phospholipases from Streptomyces. Biochemistry, 78: 363–372, 1975.
37. Desnuelle, P. The lipases. In: P. D. Boyer (ed.), The Enzymes, Vol 7. pp. 575–616. New York: Academic Press, 1972.
38. Entressangles, B., Sari, H., and Desnuelle, P. On the positional specificity of pancreatic lipase. Biochim. Biophys. Acta, 125: 597–600, 1966.
39. Waite, M. The Phospholipases (Handbook of Lipid Research 5). New York: Plenum Press, 1987.
40. Hanahan, D. J. Phospholipases. In: P. D. Boyer (ed.), The Enzymes, Vol. 5, pp. 71–85. New York: Academic Press, 1971.
41. Hirashima, Y., Farooqui, A. A., Murphy, E. J., and Horrocks, L. A. Purification of plasmalogens using Rhizopus delemar lipase and Naja naja phospholipase A2. Lipids, 25: 344–348, 1990
42. Tappel, A. L. Lipoxidase. Methods Enzymol., 5: 539–542, 1962.
43. Caselli, E., Baricordi, O. R., Melchiorri, L., Bellini, F., Ponzin, D., and Bruni, A. Inhibition of DNA synthesis in peripheral blood mononuclear cells treated with phosphatidylserine containing unsaturated acyl chains. Immunopharmacology, 23: 205–213, 1992.
44. Tokumura, A., Yube, N., Fujimoto, H., and Tsukatani, H. Lysophosphatidic acids induce contraction of Rat isolated colon by two different mechanisms. J. Pharm. Pharmacol., 43: 774–778, 1991.
45. Moolenaar, W. H., Jalink, K., and van Corven, E. J. Lysophosphatidic acid: a bioactive phospholipid with growth-factor-like properties. Rev. Physiol. Biochem. Pharmacol., 119: 47–65, 1992.
46. raf. J. Biol. Chem., 268: 20717–20720, 1993.
47. Kumagai, N., Morii, N., Fujisawa, K., Yoshimasa, T., Nakao, K., and Narumiya, S. Lysophosphatidic acid induces tyrosine phosphorylation and activation of MAP-kinase and focal adhesion kinase in culture Swiss 3T3 cells. FEBS Lett., 329: 273–276, 1993.
48. Kumagai, N., Morii, N., Fujisawa, K., Nemoto, Y., and Narumiya, S. ADP-ribosylation of rho p21 inhibits lysophosphatidic acid-induced protein tyrosine phosphorylation and phospatidylinositol 3-kinase activation. J. Biol. Chem., 268: 24535–24538, 1993.
49. ras by G protein-coupled receptor agonist in fibroblasts. Proc. Natl. Acad. Sci. USA, 90: 1257–1261, 1993.